Tipranavir Suppliers & Bulk Manufacturers
Available Forms: Capsules / Oral Solution
Available Strengths: 250 mg, 100 mg/mL
Reference Brands: Aptivus (USA/EU)
Category: Anti Viral
Tipranavir is an antiretroviral medication belonging to the protease inhibitor class. It is used in combination with ritonavir and other antiretroviral agents to treat HIV-1 infection in patients who have developed resistance to other HIV drugs. Tipranavir works by blocking the HIV protease enzyme, which prevents the virus from multiplying and lowers the amount of HIV in the blood. Tipranavir is available in Capsules / Oral Solution and strengths such as 250 mg, 100 mg/mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Tipranavir is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Tipranavir can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Tipranavir is used in combination with ritonavir and other antiretroviral medicines for the treatment of HIV-1 infection in patients who have experienced resistance to multiple protease inhibitors. It helps reduce viral load by inhibiting the HIV protease enzyme, preventing the virus from maturing and multiplying.
Tipranavir is a synthetic non-peptidic protease inhibitor. Its chemical structure is designed to bind to the active site of HIV-1 protease, blocking the enzyme’s function and preventing the formation of infectious viral particles.
The most recognized trade name for Tipranavir is Aptivus.
Aptivus is manufactured by Boehringer Ingelheim.
The generic name of the product is tipranavir.
The commonly known brand name is Aptivus.
Tipranavir (Aptivus) is manufactured by Boehringer Ingelheim in its approved global production facilities. Distribution varies by region based on regulatory approvals.
Related Products
Maraviroc
Strength:
150 mg, 300 mg, 20 mg
Form: Tablets / Oral solution
Reference Brands: Selzentry (USA), Celsentri (EU)
View DetailsRaltegravir
Strength:
100mg, 400 mg, 600mg
Form: Tablets
Reference Brands: Isentress (USA/EU)
View DetailsQuick Response Guaranteed | Verified Suppliers